云顶新耀向I-Mab投资3090万美元,加速全球化及第二增长曲线落地,同时耐赋康®扩产获批,增强造血能力。
Source Link云顶新耀向I-Mab投资3090万美元,加速全球化及第二增长曲线落地,同时耐赋康®扩产获批,增强造血能力。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.